Log In
Print
BCIQ
Print
Print this Print this
 

ricolinostat (ACY-1215) (formerly rocilinostat)

  Manage Alerts
Collapse Summary General Information
Company Acetylon Pharmaceuticals Inc.
DescriptionOral histone deacetylase 6 (HDAC6) inhibitor
Molecular Target Histone deacetylase 6 (HDAC6)
Mechanism of ActionHistone deacetylase 6 (HDAC6) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today